Gene therapies are expensive, but generic versions are emerging
Biosimilars cost on average 50% less than biologic drugs, which could save patients with things like cancer and MS, a lot of money
Stay updated with breaking news from Fran Gregory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biosimilars cost on average 50% less than biologic drugs, which could save patients with things like cancer and MS, a lot of money
Biosimilars cost on average 50% less than biologic drugs, which could save patients with things like cancer and MS, a lot of money
Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...
MOUNT ORAB, Ohio – Mount Orab Police Department were dispatched to two reported burglaries on Jan. 23 and Jan. 25 that resulted in an arrest.
The biosimilars landscape is set to witness significant growth, particularly in therapeutic areas like ophthalmology and immunology, with a focus on blockbuster biologics like Humira, Stelara, and Eylea.